C.H. Robinson's $5.8 billion RXO purchase rests on at least $300 million of synergies

Against the price, the synergy floor is modest. At least $300 million of expected synergies ^[11] is about 5.2% of the $5.8 billion Robinson is paying ^[5]. The $5.8 billion is at most about 23% of the combined enterprise value of more than $25 billion ^[6], so the merged company is worth at least 4.3 times the piece being bought ^[7]. The Seeking Alpha author who upgraded the stock calls the result the leading US logistics brokerage ^[9].

Leverage is where the deal is tight. The same author puts it at 2.9 times after closing and calls that elevated ^[3]. He or she then counts on strong free cash flow and cost reductions to bring it back to target by the end of 2028 ^[12]. Neither source gives the cash-and-stock split, the debt behind the 2.9 times, or how the $300 million divides between cost savings and revenue gains.

The two dates in the analysis sit most of a year apart. The author's $165 to $170 target is set for early 2028 and implies 24% upside ^[4]. Working back from the midpoint, that puts the starting price at about $135 ^[8]. The leverage target lands at the end of 2028 ^[12], so anyone buying at that price is paying for most of the deleveraging before it has happened.

The base case can break in more than one direction. Cost savings could land on time while revenue synergies from last-mile and expedited shipping ^[10] lag. Leverage would then fall on schedule, but the growth argument for the price would be weaker. Revenue gains could arrive while cost cuts slip, leaving the ratio above target past 2028 ^[12]. Or both could fall short, and the 2.9 times ^[3] would sit near its starting level into 2029.

For shippers, the cost-versus-revenue split decides the effect. If the savings come out of the two brokers' own costs, the rate a shipper pays stays where it was. If the synergies come from widening the gap between what a shipper pays and what a carrier receives, one side of that load pays for them.

I think the deal can survive weak revenue synergies. The deleveraging path the author lays out runs on free cash flow and cost reductions ^[12], and the full synergy floor is only about 5.2% of the price ^[5]. The case against is that the path depends on free cash flow staying strong ^[12]. If it comes in lower, the end-2028 date moves, and the early-2028 price target ^[4] arrives while the balance sheet is still stretched. Leverage near 2.9 times at the end of 2028 ^[3], or a synergy target cut below $300 million ^[11], would show the price was paid for savings that did not arrive.